(JHG) Janus Henderson - Overview
Stock: Equity Funds, Fixed-Income Funds, Balanced Funds, Private Equity, Real-Estate
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.78% |
| Yield on Cost 5y | 6.58% |
| Yield CAGR 5y | 1.47% |
| Payout Consistency | 97.8% |
| Payout Ratio | 33.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.7% |
| Relative Tail Risk | -9.64% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.34 |
| Alpha | -11.01 |
| Character TTM | |
|---|---|
| Beta | 1.386 |
| Beta Downside | 1.575 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.29% |
| CAGR/Max DD | 0.70 |
Description: JHG Janus Henderson January 08, 2026
Janus Henderson Group plc (NYSE:JHG) is a UK-based asset-management holding company that serves institutional, retail, and high-net-worth clients through a suite of equity, fixed-income, and balanced mutual funds, as well as private-equity and real-estate investments. Its product focus spans growth-capital, middle-market buyouts, and a broad set of sector exposures-including commercial services, logistics, consumer durables, hospitality, health care, financial services, REITs, and alternative-energy assets-across both public and private markets, with a particular emphasis on companies in China and India.
Key metrics as of the latest FY2023 filing show approximately $400 billion in assets under management (AUM), a net inflow of $9 billion for the year, and a dividend yield near 2.5 %. The firm’s revenue mix is roughly 55 % fee-based (management fees) and 45 % performance-based, reflecting a shift toward recurring fee structures amid industry pressure from passive alternatives. Macro drivers that materially affect Janus Henderson include global interest-rate trends (which influence fixed-income demand), the ongoing reallocation to ESG-aligned funds, and the growth of emerging-market capital flows, especially in India’s expanding middle-class consumer sector.
For a deeper, data-driven view of JHG’s valuation and risk profile, you may find it useful to explore the analytics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.06b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -0.97 > 1.0 |
| NWC/Revenue: 45.07% < 20% (prev 77.01%; Δ -31.93% < -1%) |
| CFO/TA 0.04 > 3% & CFO 311.2m > Net Income 1.06b |
| Net Debt (-858.4m) to EBITDA (685.9m): -1.25 < 3 |
| Current Ratio: 69.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (154.1m) vs 12m ago -0.44% < -2% |
| Gross Margin: 80.23% > 18% (prev 0.69%; Δ 7954 % > 0.5%) |
| Asset Turnover: 46.42% > 50% (prev 35.52%; Δ 10.90% > 0%) |
| Interest Coverage Ratio: 36.82 > 6 (EBITDA TTM 685.9m / Interest Expense TTM 17.9m) |
Altman Z'' 4.15
| A: 0.19 (Total Current Assets 1.62b - Total Current Liabilities 23.3m) / Total Assets 8.29b |
| B: 0.14 (Retained Earnings 1.18b / Total Assets 8.29b) |
| C: 0.09 (EBIT TTM 659.0m / Avg Total Assets 7.63b) |
| D: 1.75 (Book Value of Equity 5.28b / Total Liabilities 3.01b) |
| Altman-Z'' Score: 4.15 = AA |
What is the price of JHG shares?
Over the past week, the price has changed by -0.10%, over one month by +0.92%, over three months by +10.12% and over the past year by +11.75%.
Is JHG a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JHG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.1 | 4% |
| Analysts Target Price | 50.1 | 4% |
| ValueRay Target Price | 56 | 16.2% |
JHG Fundamental Data Overview February 09, 2026
P/E Forward = 10.9649
P/S = 2.405
P/B = 1.3656
P/EG = 0.9874
Revenue TTM = 3.54b USD
EBIT TTM = 659.0m USD
EBITDA TTM = 685.9m USD
Long Term Debt = 395.5m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 395.5m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -858.4m USD (from netDebt column, last fiscal year)
Enterprise Value = 6.59b USD (7.45b + Debt 395.5m - CCE 1.25b)
Interest Coverage Ratio = 36.82 (Ebit TTM 659.0m / Interest Expense TTM 17.9m)
EV/FCF = 10.40x (Enterprise Value 6.59b / FCF TTM 634.0m)
FCF Yield = 9.62% (FCF TTM 634.0m / Enterprise Value 6.59b)
FCF Margin = 17.91% (FCF TTM 634.0m / Revenue TTM 3.54b)
Net Margin = 30.01% (Net Income TTM 1.06b / Revenue TTM 3.54b)
Gross Margin = 80.23% ((Revenue TTM 3.54b - Cost of Revenue TTM 699.7m) / Revenue TTM)
Gross Margin QoQ = none% (prev 73.19%)
Tobins Q-Ratio = 0.80 (Enterprise Value 6.59b / Total Assets 8.29b)
Interest Expense / Debt = 1.54% (Interest Expense 6.10m / Debt 395.5m)
Taxrate = 22.10% (120.9m / 547.1m)
NOPAT = 513.4m (EBIT 659.0m * (1 - 22.10%))
Current Ratio = 69.46 (Total Current Assets 1.62b / Total Current Liabilities 23.3m)
Debt / Equity = 0.07 (Debt 395.5m / totalStockholderEquity, last quarter 5.28b)
Debt / EBITDA = -1.25 (Net Debt -858.4m / EBITDA 685.9m)
Debt / FCF = -1.35 (Net Debt -858.4m / FCF TTM 634.0m)
Total Stockholder Equity = 5.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.93% (Net Income 1.06b / Total Assets 8.29b)
RoE = 21.22% (Net Income TTM 1.06b / Total Stockholder Equity 5.00b)
RoCE = 12.21% (EBIT 659.0m / Capital Employed (Equity 5.00b + L.T.Debt 395.5m))
RoIC = 9.98% (NOPAT 513.4m / Invested Capital 5.14b)
WACC = 10.52% (E(7.45b)/V(7.84b) * Re(11.02%) + D(395.5m)/V(7.84b) * Rd(1.54%) * (1-Tc(0.22)))
Discount Rate = 11.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.92%
[DCF Debug] Terminal Value 70.12% ; FCFF base≈620.4m ; Y1≈644.3m ; Y5≈735.7m
Fair Price DCF = 63.21 (EV 8.59b - Net Debt -858.4m = Equity 9.44b / Shares 149.4m; r=10.52% [WACC]; 5y FCF grow 4.04% → 2.90% )
EPS Correlation: 78.20 | EPS CAGR: 30.07% | SUE: 4.0 | # QB: 7
Revenue Correlation: 72.35 | Revenue CAGR: 17.70% | SUE: 2.13 | # QB: 3
EPS next Quarter (2026-03-31): EPS=1.00 | Chg30d=+0.040 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=4.40 | Chg30d=+0.017 | Revisions Net=+2 | Growth EPS=-8.0% | Growth Revenue=-3.0%
EPS next Year (2027-12-31): EPS=4.76 | Chg30d=+0.002 | Revisions Net=+3 | Growth EPS=+8.4% | Growth Revenue=+5.3%